Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia

• Egile Nagusiak: Elisabet Rodríguez-Tomàs (Egilea), Johana C. Acosta (Egilea), Laura Torres-Royo (Egilea), Gabriel De Febrer (Egilea), Gerard Baiges-Gaya (Egilea), Helena Castañé (Egilea), Andrea Jiménez (Egilea), Carlos Vasco (Egilea), Pablo Araguas (Egilea), Junior Gómez (Egilea), Bárbara Malave (Egilea), Miguel Árquez (Egilea), David Calderón (Egilea), Berta Piqué (Egilea), Manel Algara (Egilea), Ángel Montero (Egilea), Josep M. Simó (Egilea), Xavier Gabaldó-Barrios (Egilea), Sebastià Sabater (Egilea), Jordi Camps (Egilea), Jorge Joven (Egilea), Meritxell Arenas (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The aim of our study was to investigate the changes produced by low-dose radiotherapy (LDRT) in the circulating levels of the antioxidant enzyme paraoxonase-1 (PON1) and inflammatory markers in patients with COVID-19 pneumonia treated with LDRT and their interactions with clinical and radiological c...